TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32106302

Group type: EXPERIMENTAL
Intervention: Rituximab in HHV8-MCD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-interleukin-6-directed therapies in iMCD
Number of subjects: 0
Study: 32106840

Group type: COMPARATOR
Intervention: Corn Soy Blend Plus w/ oil (CSB+ w/oil)
Number of subjects: 6112

Group type: EXPERIMENTAL
Intervention: Corn Soy Whey Blend w/oil (CSWB w/oil)
Number of subjects: 6112

Group type: EXPERIMENTAL
Intervention: Ready-to-Use Supplementary Food (RUSF)
Number of subjects: 6112

Group type: EXPERIMENTAL
Intervention: Super Cereal Plus (SC+)
Number of subjects: 6112
Study: 32106874

Group type: EXPERIMENTAL
Intervention: FES-cycling with visual biofeedback plus usual care
Number of subjects: 9
Study: 32107021

Group type: EXPERIMENTAL
Intervention: De-novo heart failure (DNHF) hospitalization
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Cardiovascular deaths
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Non-cardiovascular deaths
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Total deaths
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: DNHF hospitalizations
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Cardiovascular deaths among DNHF hospitalizations
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Non-cardiovascular deaths among DNHF hospitalizations
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Factors associated with DNHF
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 3362
Study: 32107139

Group type: EXPERIMENTAL
Intervention: Phelan-McDermid syndrome group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 10
Study: 32107167

Group type: EXPERIMENTAL
Intervention: Proportion-derivative control model applied to a virtual driving task
Number of subjects: 317
Study: 32107329

Group type: EXPERIMENTAL
Intervention: Carfilzomib, cyclophosphamide, and dexamethasone (induction and maintenance)
Number of subjects: 94
Study: 32107341

Group type: EXPERIMENTAL
Intervention: Bendamustine followed by ofatumumab and ibrutinib
Number of subjects: 66
Study: 32107605

Group type: EXPERIMENTAL
Intervention: Updated guidelines on iodinated contrast material
Number of subjects: 1992
Study: 32107674

Group type: EXPERIMENTAL
Intervention: General Organizational Index (GOI) scale administered four times over 18 months
Number of subjects: 11
Study: 32107712

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg daily)
Number of subjects: 15
Study: 32107748

Group type: EXPERIMENTAL
Intervention: Tafamidis (T-T group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tafamidis (P-T group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable (non-Val30Met group)
Number of subjects: 0
Study: 32107887

Group type: EXPERIMENTAL
Intervention: Analytical treatment interruption (ATI)
Number of subjects: 16
Study: 32108228

Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy
Number of subjects: 40
Study: 32109004

Group type: EXPERIMENTAL
Intervention: 23-h surgery model
Number of subjects: 993
Study: 32109483

Group type: EXPERIMENTAL
Intervention: Healing our Hearts, Minds and Bodies (HHMB) intervention
Number of subjects: 260
Study: 32109631

Group type: EXPERIMENTAL
Intervention: Patients with PVT
Number of subjects: 2826

Group type: COMPARATOR
Intervention: Patients with cirrhosis and AD
Number of subjects: 2826
Study: 32109839

Group type: EXPERIMENTAL
Intervention: Mango polyphenols (200-400 g of mango pulp daily for 8 weeks)
Number of subjects: 10
Study: 32110025

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (250-1500 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 32110060

Group type: EXPERIMENTAL
Intervention: Benralizumab (30 mg) administered subcutaneously at Days 0, 28, and 56
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study: 32110958

Group type: EXPERIMENTAL
Intervention: Study treatment plans (de-intensified radiotherapy)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment plans (conventional radiotherapy)
Number of subjects: 30
Study: 32111348

Group type: EXPERIMENTAL
Intervention: Oral problems associated with a low OHRQoL (GOHAI<50)
Number of subjects: 90
Study: 32111358

Group type: EXPERIMENTAL
Intervention: COMBO stent PCI
Number of subjects: 3379
Study: 32111923

Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 1900
Study: 32112737

Group type: EXPERIMENTAL
Intervention: Holmium-166 radioembolisation
Number of subjects: 30
Study: 32112982

Group type: EXPERIMENTAL
Intervention: Crizotinib (first-line therapy)
Number of subjects: 150
Study: 32113143

Group type: EXPERIMENTAL
Intervention: Cytosorb hemoperfusion
Number of subjects: 1

Group type: COMPARATOR
Intervention: IL-6 blockade and methylprednisolone
Number of subjects: 1
Study: 32113581

Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg/day for 4 days)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Terlipressin (Responders)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Non-Responders
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low portal vein pressure group
Number of subjects: 110
Study: 32113664

Group type: EXPERIMENTAL
Intervention: Preserved EF (pEF, LVEF ≥50%, N = 3526)
Number of subjects: 4005

Group type: EXPERIMENTAL
Intervention: Mid-range EF (mrEF, LVEF 41-49%, N = 302)
Number of subjects: 4005

Group type: EXPERIMENTAL
Intervention: Reduced EF (rEF, LVEF ≤40%, N = 177)
Number of subjects: 4005

Group type: COMPARATOR
Intervention: Stage C/D heart failure patients (N = 4477)
Number of subjects: 4005
Study: 32113892

Group type: EXPERIMENTAL
Intervention: Direct-acting antiviral agents (DAAs)
Number of subjects: 1760
Study: 32113974

Group type: EXPERIMENTAL
Intervention: Nonparetic hand performance in survivors of stroke
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prestroke dominant hand (DH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prestroke nondominant hand (NH)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Grip strength in survivors of stroke
Number of subjects: 40
Study: 32114500

Group type: EXPERIMENTAL
Intervention: TriMixDC-MEL IPI (dendritic cell-based mRNA vaccination plus ipilimumab)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: TriMixDC-MEL IPI
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: TriMixDC-MEL IPI or subsequent pembrolizumab treatment
Number of subjects: 39
Study: 32115672

Group type: EXPERIMENTAL
Intervention: VPA + dextromethorphan (30 mg/day) + memantine (5 mg/day) (DM30 + MM5)
Number of subjects: 66

Group type: COMPARATOR
Intervention: VPA + Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: VPA + dextromethorphan (30 mg/day) (DM30)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: VPA + memantine (5 mg/day) (MM5)
Number of subjects: 66
Study: 32116725

Group type: EXPERIMENTAL
Intervention: Angusta 25 µg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cytotec 200 µg
Number of subjects: 72
Study: 32116856

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT) with three additional sessions of Intensive Parental Coaching (IPC) after session 4.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Family-based treatment (FBT) without additional IPC.
Number of subjects: 60
Study: 32117045

Group type: EXPERIMENTAL
Intervention: Pasireotide
Number of subjects: 0

Group type: COMPARATOR
Intervention: First-generation somatostatin analogs
Number of subjects: 0
Study: 32117489

Group type: EXPERIMENTAL
Intervention: SAGES Safe Cholecystectomy Program (SCP) rules
Number of subjects: 184
Study: 32118001

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32118022

Group type: EXPERIMENTAL
Intervention: Plasmalogens treatment, specific dosage and duration not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group, specific details not available
Number of subjects: 0
Study: 32118081

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMC)
Number of subjects: 90
Study: 32118199

Group type: EXPERIMENTAL
Intervention: Targeted active malaria case detection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32118513

Group type: EXPERIMENTAL
Intervention: Fluarix Tetra
Number of subjects: 23939
Study: 32118576

Group type: EXPERIMENTAL
Intervention: Supine position during sleep
Number of subjects: 148

Group type: COMPARATOR
Intervention: Prone position during sleep
Number of subjects: 148

Group type: COMPARATOR
Intervention: Right position during sleep
Number of subjects: 148

Group type: COMPARATOR
Intervention: Left position during sleep
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Supine position versus nonsupine position
Number of subjects: 148
Study: 32118582

Group type: EXPERIMENTAL
Intervention: lipoxin A
Number of subjects: 0
Study: 32118616

Group type: EXPERIMENTAL
Intervention: Enriched, task-specific therapy
Number of subjects: 41
Study: 32119924

Group type: EXPERIMENTAL
Intervention: Single-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-Pass Endoscopic Ultrasound-Guided Fine-Needle Biopsy Sample Collection
Number of subjects: 0
Study: 32119939

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 56
Study: 32120379

Group type: EXPERIMENTAL
Intervention: Preterm group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Exercise test
Number of subjects: 102

Group type: COMPARATOR
Intervention: QT-prolonging medications
Number of subjects: 102

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 102
Study: 32120420

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging with position-tracking technology to monitor fetal head station noninvasively throughout labor.
Number of subjects: 613
Study: 32121153

Group type: EXPERIMENTAL
Intervention: Specialized coagulation service (CS) management
Number of subjects: 2272

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 2272

Group type: EXPERIMENTAL
Intervention: Both CS and usual care
Number of subjects: 2272
Study: 32122289

Group type: EXPERIMENTAL
Intervention: Severe ESUS (NIHSS ≥6)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Mild ESUS (NIHSS <6)
Number of subjects: 772
Study: 32122334

Group type: EXPERIMENTAL
Intervention: Peritraumatic Dissociative Experiences Questionnaire (PDEQ)
Number of subjects: 647

Group type: EXPERIMENTAL
Intervention: PDEQ
Number of subjects: 647

Group type: EXPERIMENTAL
Intervention: PDEQ and other significant risk indicators
Number of subjects: 647
Study: 32122345

Group type: EXPERIMENTAL
Intervention: FCH imaging modality
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3 imaging modalities
Number of subjects: 0
Study: 32122366

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange (TPE)
Number of subjects: 31
Study: 32122899

Group type: EXPERIMENTAL
Intervention: Cefpirome 2 g every 8 h for intravenous bolus injection or 2 g every 12 h for extended infusion over 4 h
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cefpirome during ECMO-ON
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cefpirome during ECMO-OFF
Number of subjects: 15
Study: 32122924

Group type: EXPERIMENTAL
Intervention: Tazemetostat (EPZ-6438) 800 mg twice a day plus R-CHOP
Number of subjects: 17

Group type: COMPARATOR
Intervention: R-CHOP alone
Number of subjects: 17
Study: 32123139

Group type: EXPERIMENTAL
Intervention: Exposure to secondhand aerosol from e-cigarettes (SHA)
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Other indoor settings (e.g., bar and restaurant)
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Workplace/educational venues
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Home
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Public transportation
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Private transportation
Number of subjects: 11604

Group type: EXPERIMENTAL
Intervention: Demographic factors (men, younger age groups, higher education, e-cigarette past users, current smokers, those perceiving SHA harmless, living in higher e-cigarette use prevalence countries)
Number of subjects: 11604
Study: 32123534

Group type: EXPERIMENTAL
Intervention: MVM supplementation (single dose on Day 1 and 4-week supplementation on Day 28)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: MVM supplementation (4-week supplementation on Day 28)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: MVM supplementation (single dose on Day 1)
Number of subjects: 82
Study: 32124210

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding (LAGB)
Number of subjects: 242
Study: 32124317

Group type: EXPERIMENTAL
Intervention: OpenVax computational workflow for identifying somatic variants and predicting neoantigens
Number of subjects: 0
Study: 32125175

Group type: EXPERIMENTAL
Intervention: Vorinostat
Number of subjects: 0

Group type: COMPARATOR
Intervention: BRAFi/MEKi
Number of subjects: 0
Study: 32125255

Group type: EXPERIMENTAL
Intervention: MRI with specific absorption rate (SAR) measurements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32125711

Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (RT)
Number of subjects: 239
Study: 32125874

Group type: EXPERIMENTAL
Intervention: Controlled Ozone Exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ambient Ozone or Other Pollutants
Number of subjects: 0
Study: 32125878

Group type: EXPERIMENTAL
Intervention: Costal chondrocyte-derived pellet-type autologous chondrocyte implantation (CCP-ACI)
Number of subjects: 7
Study: 32125937

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg per day for 6 months
Number of subjects: 79
Study: 32126141

Group type: EXPERIMENTAL
Intervention: Rituximab/bendamustine (RB) followed by rituximab/high-dose cytarabine (RC)
Number of subjects: 88
Study: 32126156

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Pain (CBT-P)
Number of subjects: 113
Study: 32126942

Group type: COMPARATOR
Intervention: Pre-ICH SSRI use
Number of subjects: 2287

Group type: EXPERIMENTAL
Intervention: New post-ICH SSRI use
Number of subjects: 2287
Study: 32126971

Group type: EXPERIMENTAL
Intervention: Preoperative pain by peripheral venous cannulation (PVC) - PVC-Low (NRS ≤ 2)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: PACU nurses' expectations of patients' pain levels
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Patients' early pain levels at the PACU
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Patients' own forecast of postoperative pain levels
Number of subjects: 102
Study: 32126985

Group type: EXPERIMENTAL
Intervention: Mobile Apps
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Mobile Apps (Trainees)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Mobile Apps (Specialists)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Smartphone Peripherals (Trainees)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Smartphone Peripherals (Specialists)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Mobile Apps Usage (Trainees)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Mobile Apps Usage (Specialists)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Usefulness of Apps
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Usefulness of Peripherals
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Confidence in Smartphone Peripherals
Number of subjects: 349
Study: 32126998

Group type: EXPERIMENTAL
Intervention: PACIC scale (Patient Assessment of Chronic Illness Care)
Number of subjects: 1378
Study: 32127922

Group type: EXPERIMENTAL
Intervention: Early systematic supplemental parenteral nutrition (SPN) in combination with nutritional counseling (NC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutritional counseling (NC) alone
Number of subjects: 0
Study: 32128106

Group type: EXPERIMENTAL
Intervention: PCOS+OSA (women with PCOS and OSA, ODI ≥ 5)
Number of subjects: 39

Group type: COMPARATOR
Intervention: PCOS only (women with normal ESS and low-risk Berlin questionnaire, or normal sleep studies, ODI < 5)
Number of subjects: 39
Study: 32128228

Group type: EXPERIMENTAL
Intervention: Multi-target stool DNA (mt-sDNA) assay (Cologuard)
Number of subjects: 150000
Study: 32128249

Group type: EXPERIMENTAL
Intervention: Music (modified classical music) delivered three times a day for 30 minutes with noise cancelation headphones
Number of subjects: 60

Group type: COMPARATOR
Intervention: Noise cancelation (sham playlist) delivered three times a day for 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care with no specific intervention
Number of subjects: 60
Study: 32128326

Group type: EXPERIMENTAL
Intervention: Rapid, multipathogen respiratory panel (RP) test
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 191
Study: 32128723

Group type: EXPERIMENTAL
Intervention: Clinical judgement of anesthetic depth by EEG-blinded anesthesiologists
Number of subjects: 600

Group type: COMPARATOR
Intervention: Narcotrend monitor
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Clinical judgement of anesthetic depth
Number of subjects: 600
Study: 32128923

Group type: EXPERIMENTAL
Intervention: Gastric Bypass
Number of subjects: 2007

Group type: EXPERIMENTAL
Intervention: Gastric Banding
Number of subjects: 2007

Group type: EXPERIMENTAL
Intervention: Vertical Banded Gastroplasty
Number of subjects: 2007

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 2007
Study: 32128975

Group type: EXPERIMENTAL
Intervention: Bacterascites
Number of subjects: 418

Group type: COMPARATOR
Intervention: Culture-positive SBP
Number of subjects: 418
Study: 32129666

Group type: EXPERIMENTAL
Intervention: Quality Improvement Initiative to Increase Mother's Own Milk Use
Number of subjects: 0
Study: 32129861

Group type: EXPERIMENTAL
Intervention: 40 mg/kg/day, q8h, IV drip 3 h
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 80 mg/kg/day (continuous infusion)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 160 mg/kg/day (continuous infusion)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 20-160 mg/kg/day
Number of subjects: 99
Study: 32130110

Group type: EXPERIMENTAL
Intervention: Fun for Wellness (FFW)
Number of subjects: 461
Study: 32130178

Group type: EXPERIMENTAL
Intervention: HealthMindr app (intervention arm)
Number of subjects: 657

Group type: COMPARATOR
Intervention: HealthMindr app (control arm)
Number of subjects: 657
Study: 32130186

Group type: EXPERIMENTAL
Intervention: 21-day Brush Day & Night intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (free toothpaste and toothbrushes)
Number of subjects: 20
Study: 32130192

Group type: EXPERIMENTAL
Intervention: Outsmart HPV content on the Web with monthly unidirectional vaccination reminders sent via text messages
Number of subjects: 1995

Group type: EXPERIMENTAL
Intervention: Outsmart HPV content on the Web with monthly interactive vaccination reminders sent via text messages
Number of subjects: 1995

Group type: COMPARATOR
Intervention: Standard information on the Web about HPV vaccine
Number of subjects: 1995
Study: 32130196

Group type: EXPERIMENTAL
Intervention: PrEP mobile messaging intervention (interactive text messages over 4 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Enhanced standard of care (ESC)
Number of subjects: 66
Study: 32130199

Group type: EXPERIMENTAL
Intervention: Cinematographic recordings of lumbar spine motion during maximum flexion and extension
Number of subjects: 11
Study: 32130406

Group type: EXPERIMENTAL
Intervention: MRD-negative group
Number of subjects: 65

Group type: COMPARATOR
Intervention: MRD-positive group
Number of subjects: 65
Study: 32130814

Group type: EXPERIMENTAL
Intervention: Combined biopsy
Number of subjects: 2103

Group type: COMPARATOR
Intervention: MRI-targeted biopsy
Number of subjects: 2103

Group type: COMPARATOR
Intervention: Systematic biopsy
Number of subjects: 2103
Study: 32130813

Group type: EXPERIMENTAL
Intervention: Combination of bedaquiline, pretomanid, and linezolid
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 109
Study: 32131045

Group type: EXPERIMENTAL
Intervention: Online health diary program (SMARTLog) with dynamic feedback, users completed 61 or more SMARTLogs (n=25, 33% of the sample)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Online health diary program (SMARTLog) with dynamic feedback, users generated 11 or more new SMARTProfiles (n=23, 30% of the sample)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cumulative number of SMARTLogs completed
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cumulative number of SMARTProfiles received
Number of subjects: 76
Study: 32131056

Group type: EXPERIMENTAL
Intervention: Argus I implant
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Argus II implant
Number of subjects: 1
Study: 32131687

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 2237
Study: 32131742

Group type: EXPERIMENTAL
Intervention: Renally inappropriate medications (RIMs)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medications (PIMs)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors and allopurinol
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Specific medications identified for deprescription
Number of subjects: 556
Study: 32131842

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (400, 600, and up to 800 U)
Number of subjects: 155
Study: 32131847

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 1462

Group type: EXPERIMENTAL
Intervention: Increasing moderate-to-vigorous physical activity (MVPA)
Number of subjects: 1462

Group type: EXPERIMENTAL
Intervention: Substituting sedentary time (ST) with light intensity physical activity (LIPA)
Number of subjects: 1462
Study: 32131878

Group type: EXPERIMENTAL
Intervention: Controlled alterations in ET O2 and CO2 levels during mechanical ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age-related responses to controlled alterations in ET gas tensions
Number of subjects: 0
Study: 32131882

Group type: EXPERIMENTAL
Intervention: Quality indicators for structure and process
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: Quality indicators for outcome
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: Between-centre variation
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: Statistical uncertainty of outcome indicators
Number of subjects: 2006